Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer-Reference-Cited by-同舟云学术

Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer

Published:2004-12 Issue:6 Volume:10 Page:1032-1042
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Shaw Tanya J.,Senterman Mary K.,Dawson Kerri,Crane Colleen A.,Vanderhyden Barbara C.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference57 articles.

1. SEER Cancer Statistics Review 1973–1999, Table I-15;National Cancer Institute,2003

2. Atlas of Tumor Pathology;Scully,1998

3. Expression of growth hormone-releasing hormone in human primary endometrial carcinomas;Chatzistamou;Eur. J. Endocrinol.,2002

4. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo;Tsukagoshi;Int. J. Oncol.,2003

5. Heterotransplantation of a human malignant tumour to “Nude” mice;Rygaard;Acta Pathol. Microbiol. Scand.,1969

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice;Scientific Reports;2024-05-24

2. Orthotopic and metastatic tumour models in preclinical cancer research;Pharmacology & Therapeutics;2024-05

3. Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells;Cell Death & Disease;2024-04-04

4. A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors;Journal of Controlled Release;2024-04

5. Biology-driven therapy advances in high-grade serous ovarian cancer;Journal of Clinical Investigation;2024-01-02